Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation

Area of Science:

• Stem cell biology
• Molecular biology
• Cancer research

Background:

• The tumor suppressor protein p53 plays a critical role in cellular responses to stress.
• p53's precise role in regulating induced pluripotent stem cell (iPSC) generation remains largely undefined.
• Understanding p53's influence is key to optimizing iPSC production for regenerative medicine and disease modeling.

Purpose of the Study:

• To investigate the impact of p53 inactivation and temporal reactivation on somatic cell reprogramming into iPSCs.
• To explore the effects of various p53 mutant alleles on the efficiency and stability of iPSC formation.
• To elucidate the molecular mechanisms by which p53 influences epigenetic reprogramming and stem cell fate.

Main Methods:

• Utilized a temperature-sensitive mutant of the Trp53 gene to control wild-type p53 expression temporally.
• Examined the reprogramming process in somatic cells under conditions of p53 deficiency and reactivation.
• Analyzed the expression of p53-regulated genes (e.g., p21, Puma) and their role in iPSC generation.
• Assessed epigenetic stability and differentiation markers in iPSCs derived from p53-deficient or manipulated cells.

Main Results:

• Complete or partial inactivation of p53 significantly enhances iPSC production efficiency and reduces latency.
• Temporal reactivation of p53 during reprogramming inhibits iPSC formation and induces differentiation of newly formed stem cells.
• p21 (Cdkn1a), but not Puma (Bbc3), partially contributed to iPSC formation, likely by regulating cell division.
• p53 activation in established iPSCs induced senescence and differentiation, while its absence in mice correlated with epigenetic instability.
• p53 deficiency accelerated iPSC production from cancer cells, suggesting broader applicability of p53 inhibition.

Conclusions:

• p53 acts as a significant barrier to efficient somatic cell reprogramming into iPSCs.
• Modulating p53 activity offers a powerful strategy to improve iPSC generation from both normal and cancerous cells.
• The absence of p53 may lead to epigenetic instability, necessitating careful consideration for therapeutic applications.